CRISPR is a gene-editing technology that allows scientists to precisely alter DNA sequences in living organisms using a guide RNA and a specialized endonuclease enzyme.
UPSC evaluates CRISPR under General Studies Paper III, focusing on its operational mechanism and applications in healthcare and agriculture compared to conventional genetic modification. Questions often test the regulatory landscape, particularly India's guidelines for safety assessment of genome-edited plants and exemptions granted to specific categories. Candidates must also analyze the socio-economic and ethical dimensions, including equitable access to expensive gene therapies and biosecurity risks.
Nothing filed against CRISPR yet. As the day’s reading is published, entries that touch it collect here, newest first.